全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1335210-23-5 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester | C13H17NO8 |
| 1335210-24-6 | Cabotegravir Intermediate;(3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid | C13H14N2O6 |
| 1335210-26-8 | Methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate | C11H19NO6 |
| 1335210-34-8 | (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid;(3S,7R)-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxylic acid | C14H16N2O6 |
| 1335210-35-9 | (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | C21H21F2N3O5 |
| 1335316-40-9 | (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline | C13H22N2O5 |
| 1335523-82-4 | (3S)-3-(4-Bromophenyl)piperidine | C11H14BrN |
| 1337482-15-1 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-3'-uridylyl]-L-alanine 1-methylethyl ester | C22H29FN3O9P |
| 1337531-36-8 | 7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;GSK 2606414 | C24H20F3N5O |
| 1337532-29-2 | 5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C23H21FN6O |
| 1337532-51-0 | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C7H7BrN4 |
| 1337879-62-5 | 7-Bromo-4-methoxy-1H-indazole | C8H7BrN2O |
| 1337880-06-4 | 6-Bromo-7-methyl-1H-indazole | C8H7BrN2 |
| 1337881-26-1 | 4-Bromo-7-methyl-1H-indazol-3-amine | C8H8BrN3 |
| 1337883-32-5 | ((3-(3-Methyl-3H-diazirin-3-yl)propamino)carbonyl)-Nepsilon-L-lysine;DiZPK | C12H23N5O3 |
| 1337967-93-7 | 5,5'-[(Tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)bis(sulfonyl)]bis[isoquinoline] | C23H22N4O4S2 |
| 1338225-97-0 | 3-Chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile | C17H11ClF3N5O3 |
| 1338226-21-3 | 5-(Chloromethyl)-2,4-dihydro-4-methyl-3H-1,2,4-triazol-3-one | C4H6ClN3O |
| 1338247-30-5 | cyclopropanecarboxamide | C17H12Cl2F2N4OS |
| 1338247-35-0 | N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide | C17H14Cl2F2N4OS |
| 1338446-77-7 | 9-[3-(Dibenzo[b,d]furan-2-yl)phenyl]-9H-carbazole | C30H19NO |
| 1338466-77-5 | EPZ 004777;7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C28H41N7O4 |
| 1338540-63-8 | (R)-9-[4-(1-Aminopropan-2-yl)phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one | C21H20N2O2S |
| 1338545-07-5 | (R)-9-[4-[1-(Dimethylamino)propan-2-yl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one Hydrochloride | C23H24N2O2S.HCl |
| 1338575-28-2 | 2-(3-Methoxypropyl)-1-piperidinecarboxylic acid 4-nitrophenyl ester | C16H22N2O5 |
| 1338823-35-0 | N6-(1-Oxo-2-buten-1-yl)-L-lysine | C10H18N2O3 |
| 1338925-11-3 | N-1-Naphthalenyl-1-pentyl-1H-indole-3-carboxamide | C24H24N2O |
| 1338925-12-4 | N-2-Naphthalenyl-1-pentyl-1H-indole-3-carboxamide | C24H24N2O |
| 1338990-46-7 | 2-Amino-4-pyridinecarboxylic acid 1,1-dimethylethyl ester | C10H14N2O2 |
| 1339928-25-4 | N-Hydroxy-2-[[[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl](methyl)amino]pyrimidine-5-carboxamide;CUDC 907 | C23H24N8O4S |
| 1340024-54-5 | Ibuprofen Impurity 40;6-Isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one | C14H18O |
| 1340313-49-6 | 2-Bromo-5-(difluoromethyl)-1,3,4-thiadiazole | C3HBrF2N2S |
| 1340593-59-0 | Oteseconazole;(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol | C23H16F7N5O2 |
| 1341200-45-0 | 2-[[5-Chloro-2-[[4-[(4-methyl-1-piperazinyl)methyl]phenyl]amino]-4-pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide | C24H30ClN7O2S |
| 1341216-35-0 | 4-Amino-2-fluorophenol hydrochloride | C6H6FNO.HCl |
| 1342276-76-9 | 1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea | C17H16N4O2S |
| 1342278-01-6 | 1-(3-Hydroxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea;RKI 1447 | C16H14N4O2S |
| 1342547-91-4 | 5,5-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | C10H14N2O2 |
| 1342819-12-8 | 2-Chloro-4-(2-naphthalenyl)-6-phenyl-1,3,5-triazine | C19H12ClN3 |
| 1343403-10-0 | (3R,3aS,3bS,6aS,8aS,9aR)-Octahydro-3-hydroxy-3,8a-dimethyl-6-methylene-1H-oxireno[8,8a]azuleno[4,5-b]furan-5(6H)-one | C15H20O4 |
| 1344109-54-1 | 3,5-Difluoro-4-(1-methylethoxy)benzoic acid | C10H10F2O3 |
| 1344264-52-3 | 2-(2,6-Difluorophenyl)-2,2-difluoroacetic acid | C8H4F4O2 |
| 1344876-77-2 | 1-(3-Hydroxy-1-pyrrolidinyl)-3-phenyl-2-propen-1-one | C13H15NO2 |
| 1345021-52-4 | 3-(3,5-Dibromophenyl)-9-phenyl-9H-carbazole | C24H15Br2N |
| 1345037-05-9 | [3-Chloro-4-(trifluoromethyl)phenyl]acetic acid ethyl ester;Ethyl 2-(3-chloro-4-(trifluoromethyl)phenyl)acetate | C11H10ClF3O2 |
| 1345098-78-3 | 5,11-Dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | C23H24N6O2 |
| 1345413-20-8 | (1S,2R)-2-(3,4-Difluorophenyl)-cyclopropanamine | C9H9F2N |
| 1345461-33-7 | 1,6-Naphthyridine-5,7(6H,8H)-dione | C8H6N2O2 |
| 1345614-59-6 | 4'-[3-Methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid sodium salt (1:1);AM 095 | C27H24N2O5.Na |
| 1345628-08-1 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-anthracenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide | C45H31O4P |